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Abstract
Background: The use of cardiovascular health services is greater among patients with depressive symptoms than
among patients without. However, the extent to which such associations between depressive symptoms and
health service utilization are attributable to variations in comorbidity and prognostic disease severity is unknown.
This paper explores the relationship between depressive symptoms, health service cardiovascular consumption,
and prognosis following acute myocardial infarction (AMI).
Methods: The study design was a prospective cohort study with follow-up telephone interviews of 1,941 patients
30 days following AMI discharged from 53 hospitals across Ontario, Canada between December 1999 and
February, 2003. Outcome measures were post discharge use of cardiac and non-cardiac health care services. The
service utilization outcomes were adjusted for age, sex, income, comorbidity, two validated measures of
prognosis (cardiac functional capacity and risk adjustment severity index), cardiac procedures (CABG or PTCA)
and drugs prescribed at discharge.
Results: Depressive symptoms were associated with a 24% (Adjusted RR:1.24; 95% CI:1.19–1.30, P < 0.001), 9%
(Adjusted RR:1.09; 95% CI:1.02–1.16, P = 0.007) and 43% (Adjusted RR: 1.43; 95% CI:1.34–1.52, P < 0.001)
increase in total, cardiac, and non-cardiac hospitalization days post-AMI respectively, after adjusting for baseline
patient and hospital characteristics. Depressive-associated increases in cardiac health service consumption were
significantly more pronounced among patients of lower than higher cardiac risk severity. Depressive symptoms
were not associated with increased mortality after adjusting for baseline patient characteristics.
Conclusion: Depressive symptoms are associated with significantly higher cardiac and non-cardiac health service
consumption following AMI despite adjustments for comorbidity and prognostic severity. The disproportionately
higher cardiac health service consumption among lower-risk AMI depressive patients may suggest that health
seeking behaviors are mediated by psychosocial factors more so than by objective measures of cardiovascular risk
or necessity.
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Available evidence has demonstrated that health service
consumption is higher among patients with depression
than those without. In ambulatory care settings, depres-
sion is associated with a 50% increase in general medical
service use, even after adjusting for age, sex and chronic
medical comorbidities[1,2]. Similar depression-related
service consumption patterns have been described among
cohorts with cardiovascular disease[3,4].
Some authors advocate that increased health service con-
sumption among cardiac-specific patients with depres-
sion is appropriate and concordant with their underlying
cardiovascular prognosis[5]. However, others contend
that depressed patients seek more health care services
regardless of illness severity. Evidence from utilization
patterns of depressed patients in primary care settings sug-
gest that depressed patients use more health care services
than non-depressed patients regardless of medical illness
severity [6]. Few studies have quantified the relationship
between depressive symptoms, illness severity, and health
service consumption.
Accordingly, the objective of our study was to evaluate the
impact of depressive symptoms on health service con-
sumption and cardiovascular prognosis following AMI.
AMI serves as a useful test case because the natural history
of the disease has been well-described[7] and validated
measures of cardiac prognostic risk severity exist[8]. Yet,
unexplained variations in health service consumption
exist across patient populations[9,10]; similar health serv-
ice consumption variations may be explained by psycho-
social factors. Because Canada's federal-provincial
Medicare plan covers medically necessary services based
on need rather than affordability[11], differences in
health service consumption are more likely to reflect dif-
ferences in health service behaviors than in a system
where services are provided based on an ability to pay [3].
We hypothesized that health service consumption follow-
ing AMI would be increased among patients with depres-
sive symptoms as compared to those without and would




Canada's universal health insurance system provides com-
prehensive coverage for most medical and hospital serv-
ices without user fees at point of service. Under such
provisions, patients are entitled to equitable access to
health care services based on medical need, regardless of
age, financial status, or financial circumstances[11].
Data source and study sample
This study is a sub-study of the Socio-Economic and Acute
Myocardial Infarction Study (SESAMI) study, a prospec-
tive observational study of patients who were hospitalized
for AMI throughout Ontario, Canada[10]. Patients were
included if they were English-speaking and if 2 of 3 AMI
criteria were met: presence of symptoms, abnormal elec-
trocardiographic findings, or elevated serum levels of car-
diac enzymes. Patients were excluded if they were younger
than 19 years of age or older than 101 years of age, lacking
a valid health card number issued by the province of
Ontario, and those who were transferred to the recruiting
hospital. Eligibility for the study required completion of a
self-administered baseline survey; patients who died
within 24 hours of admission, who had very severe illness,
who had language barriers, or who underwent early dis-
charge or transfer were therefore ineligible. Data came
from four sources: 1) a baseline survey; 2) chart abstrac-
tion from index AMI; 3) a one-month follow-up phone
survey; and 4) linked health administrative data. From
2829 patients with successfully abstracted index AMI
admissions and linked health administrative data, 888
(31%) subjects did not complete the one-month follow-
up survey either because of death prior to the survey (N =
73; 2%) or a refusal to participate (N = 815; 29%). A total
of 1941 (69%) patients remained available for analysis.
The SESAMI cohort has been described in detail else-
where[10]. The Sunnybrook Health Sciences Centre
Review Committee approved this study and all subjects
gave informed consent to participate.
Depressive symptom measures
The SESAMI survey consisted of psychometric questions
that explored various domains related to depression,
including low mood, loss of interest, sleep disturbance,
reduced appetite/wt loss, agitation/slowing, low self-
esteem/guilt, suicidal thoughts, reduced energy level, loss
of concentration (Table 1). The SESAMI surveys were tele-
phone administered by standardized trained health care
personnel (nurses).
Nine of twelve questions were directly abstracted from the
Brief Carroll Depression Rating Scale (BCDRS). These
nine questions served as our primary determinant of
depressive symptoms. The original 12-item BCDRS is a
depression rating scale which has been validated among
hospitalized mentally ill populations, and has a sensitiv-
ity of 92% and a specificity of 89% using a cut-off scale of
6 [12].
While a score of 6 or more of the original 12-item BCDRS
has been used to define depression, affirmative responses
to 5 or more of the 9 administered BCDRS items were
used to define patients as having "depressive symptoms"
for the purposes of our study. A score of 5 rather than 6Page 2 of 12
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median score of 6, and because five or more depressive
constructs are required to fulfill DSM-IV criteria for
depression, and hence is concordant with the diagnostic
criterion threshold from DSM-IV [13].
The three questions comprising the 12-item BCDRS not
included in the SESAMI survey, related to sleep distur-
bance, concentration, and self-esteem, and were as fol-
lows:: "my sleep is restless and disturbed"; "I can
concentrate easily when reading the paper"; and "I feel
worthless and ashamed about myself". However, these
missing questions were replaced with the following: "Dur-
ing the past week, how much time have you had trouble
sleeping for example, having trouble falling asleep or wak-
ing up too early and unable to get back to sleep"; "During
the past week, how much of the time have you had trou-
ble concentrating or keeping your mind on what you're
doing?"; and "You are a burden on others" (Table 1).
These three items were abstracted from two data sources:
The first two replacement items originated from a depres-
sion measure incorporated within the Global Utilization
of Streptokinase and t-PA for Occluded Coronary Arteries
(GUSTO) trial quality of life substudy [14], whose design
served as the foundation for the SESAMI[15]. The remain-
ing replacement item originated from the SF-12. For scor-
ing purposes, responses related to the first 2 replacement
questions were dichotomized around the median (3+
days per week vs. < 2 days per week). The last replacement
question elicited a binary response (Table 1). These three
additional replacement questions were analyzed sepa-
rately from the 9-item BCDRS and reported within the
sensitivity analysis section below.
Demographic factors
Demographic factors such as age, sex, and income tertile
were acquired from the baseline survey and were based on
patient self-report.
Cardiovascular risk severity
Two validated measures of cardiovascular risk-severity
were used in this study:
The first measure was the Global Registry of Acute Coro-
nary Events (GRACE) prognostic index. The GRACE prog-
nostic index provides a score that reflects the probability
of dying within 6 months post-AMI based on age, devel-
opment (or history) of heart failure, peripheral vascular
disease, systolic blood pressure, Killip class, initial serum
creatinine concentration, elevated initial cardiac markers,
cardiac arrest on admission, and ST segment deviation[8].
The GRACE prognostic index has been validated among
SESAMI patients[16]. In addition to the GRACE prognos-
tic index, we examined other cardiovascular risk factors,
Table 1: BCDRS* items (included and missing) and replacement items from SESAMI survey
Depression Questions Item Questionnaire Depression Construct
I am losing weight. BCDRS Loss of appetite/weight loss
I have dropped many of my interests and activities. BCDRS Loss of interest
It must be obvious that I am disturbed and agitated. BCDRS Psychomotor agitation.
I am miserable or often feel like crying. BCDRS Low mood
I often wish I were dead. BCDRS Suicidal thoughts.
I feel in good spirits. BCDRS Low mood.
I still enjoy my meals. BCDRS Loss of appetite.
I get hardly anything done lately. BCDRS Low motivation.
I am exhausted much of the time. BCDRS Low energy.
My sleep is restless and disturbed. BCDRS (missing) Disturbed sleep
I can concentrate easily when reading the papers. BCDRS (missing) Poor concentration
I feel worthless and ashamed about myself. BCDRS (missing) Low self-esteem
Replacement Items
During the past week how much of the time have you had trouble 
sleeping for example, having trouble falling asleep or waking up 
too early and unable to get back to sleep?*
GUSTO Trial Psychological Well-being Scale[14] Disturbed sleep
During the past week, how much of the time have you had 
trouble concentrating or keeping your mind on what you're 
doing?*
GUSTO Trial Psychological Well-being Scale[14] Poor concentration
You are a burden on others SF-12 Low self-esteem
*The BCDRS and SF-12 items were dichotomous (yes/no). The GUSTO trial items had 4 options from None of the time, some of the time (1–2 
days/wk), some of the time (3–4 days/wk), and All/most of the time (5 or more days/wk). The GUSTO items were dichotomized around the median 
of 3 or more days/wk.Page 3 of 12
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and current or former cigarette use. Smoking history was
ascertained by questionnaire. Major cardiovascular risk
factors were determined by reviewing diagnostic fields in
computerized hospital discharge abstracts from April 1,
1988 to the index hospitalization date using all primary
and secondary ICD-9 and ICD-10 (where applicable) dis-
charge codes. Agreement between self-reported risk fac-
tors and chart audit range was between 73%
(hyperlipidemia) and 95% (diabetes) [10].
The second measure was the Duke Activity Status Index
(DASI), administered to all participants. The DASI is a
self-report measure validated to determine functional
capacity which correlates well with peak oxygen
uptake[17], one of the most important single predictors of
long-term cardiovascular survival across populations[18].
Preexisting noncardiovascular comorbid conditions
Noncardiovascular risk factors consisted of all co-morbid
diseases that were captured through primary and second-
ary diagnostic fields of hospital discharge abstracts (Cana-
dian Institute for Health Information) from 1 April 1988
to the presenting hospitalization. This method has been
used and demonstrated to increase the prevalence of
chronic conditions, which historically are known to be
under-coded using single data sources alone[19,20]. Fur-
thermore, supplementing clinical data sources with
longer retrospective ascertainment of comorbidities using
administrative data has been shown to improve accuracy
[21]. Non-cardiovascular conditions were categorized as
cancer and as diseases of the central nervous system,
endocrine system, hematology system, musculoskeletal
system, respiratory system, gastrointestinal system, and
genitourinary system. We categorized diabetes, secondary
hypertension, and hyperlipidemia as cardiovascular risk
factors, not as diseases of the endocrine system[22]. Avail-
able evidence has demonstrated that the number of non-
cardiac comorbidities have independent prognostic sig-
nificance in patients with cardiovascular illness[23]. For
the purposes of our study, non-cardiac comorbidities were
analyzed as a count variable (0, 1, 2 or 3 or more). How-
ever, a re-analysis of our data in which we incorporated
both the count, and the type of non-cardiac comorbidity
did not alter our results.
Early peri-infarction procedure and medication use
All of our outcomes could be influenced by whether or
not a patient has received revascularization by angioplasty
or coronary bypass surgery. All revascularization proce-
dures occurring within 30 days of discharge from the
index AMI hospitalization were recorded within the
Ontario Health Insurance Program database. In addition,
we examined the influence of cardiovascular medication
(Beta-blockers, statins, ACE inhibitors, and nitrates) pre-
scribed at discharge from index admission as acquired
from chart abstraction.
Outcomes
Our primary outcomes included cumulative outpatient
physician and emergency room visits, the number and
duration of recurrent hospitalizations, as well as total hos-
pitalizations and ambulatory physician visits over the 18
months following index AMI hospitalization discharge.
These outcomes were chosen because they reflect health
care consumption measures that can be accurately meas-
ured in the linked administrative health data sets. Second-
ary outcomes included mortality, recurrent AMI, as well as
time to first re-admission for cardiac-specific readmis-
sions as general measures of prognosis. We examined
recurrent AMI hospitalizations separately from other
cause-specific admissions because recurrent AMI repre-
sents a deleterious prognostic outcome indicator. Moreo-
ver, unlike our other hospitalizations which are based on
more discretionary criteria, recurrent AMI admissions are
based on more standardized, objective clinical, labora-
tory, and ECG parameters. However, a re-analysis in
which recurrent AMI was categorized together with the
other health service consumption variables did not alter
our results. Recurrent AMI was defined using the most-
responsible diagnosis field of ICD-9 and ICD-10[24]. Car-
diac specific re-admissions were ascertained using sets of
the CIHI most-responsible diagnosis codes (AMI: ICD-9
410, 412, 4141; ICD-10 I21, I22, and I2382; angina: ICD-
9 411, 413, 4140, and 4142–4149; ICD-10 I20, I241,
I251, I252, I253, and I258; CHF: ICD-9 428, 415, 4254,
4298; ICD-10 I50, I255, I420, I429) that a previous study
has shown have modest sensitivity, but high specifi-
city[24].
Statistical analysis
The Mantel-Haenszel test for trend was used for categori-
cal data and t-tests (or nonparametric tests where rele-
vant) were used for continuous data to detect unadjusted
differences in baseline characteristics. We estimated Pois-
son regression models for rates of service utilization, as
well as Cox proportional hazard models for mortality,
recurrent AMI, and time to first angina hospitalization,
adjusting for age, sex, income, cardiac risk factors, total
medical comorbidities, prognostic index (GRACE score[8]
and DASI[17]), drugs at discharge, and peri-infarction
procedures using non-parsimonious modeling. Formal
diagnostic testing revealed no evidence of multi-collinear-
ity in any of our statistical models. We tested for viola-
tions of the proportionality assumption in all
proportional hazard model specifications. Finally, for the
health service utilization multivariable models, we used
generalized estimating equations (GEE) to adjust for hos-
pital-level variations in patient care.Page 4 of 12
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version 9.1 (SAS Institute, Cary, NC).
Sensitivity analyses
We conducted a number of sensitivity and sub-group
analyses. First, we examined the relationship between the
3 replacement questions and health service utilization.
Second, we examined the use of different cut-off scores to
define "depressive symptoms" for both the 9-item BCDRS
and the 3 depressive-symptom replacement items. Finally,
multiple imputation was used to impute depression
measures for the 888 missing depression values due to
non-response[25] to test whether our outcomes were
affected by systematic differences between survey
responders and non-responders. Variables used to model
the missing data included demographic variables (age,
sex, SES), cardiac risk factors and illness severity (GRACE
prognostic index and DASI), revascularization proce-
dures, drugs prescribed at discharge, and the 9-item
depression scale. There was no difference between aggre-
gated results from 5 and 10 imputed data sets; results from
5 imputed data sets are reported. The missing depression
measures were imputed using PROC MI and the results
from the multiple, imputed data sets were aggregated




The 888 (31%) patients who did not respond to the one
month follow-up survey were similar to the 1941 subjects
in terms of gender, cardiac risk factors, likelihood of
receiving revascularization procedures within 30 days of
discharge, and the likelihood of receiving ACE inhibitors,
Beta blockers, and nitrates upon discharge. However, the
sample of 888 survey non-respondents were older (mean
(SD) age of respondents 66.3 (13.7) years vs. 62.4 (12.8)
years; P < 0.001), more likely to have 3 or more non-car-
diac medical comorbidities (55.7% vs. 47.2%; P < 0.001),
less likely to receive statins upon discharge (48.7% vs.
54.9%; P = 0.002), and had a higher GRACE score (predic-
tive of 6 month mortality)(4.1 vs. 3.2; P < 0.001) than the
1941 survey respondents who consented and completed
the 1 month post-myocardial infarction evaluation.
Among the 1941 subjects included in this study, the
median age was 64 years (range, 26 to 96 years). 575
(29.6%) were women. Table 2 illustrates that the baseline
characteristics of patients reporting five or more depres-
sive symptoms differed from those reporting fewer
depressive symptoms. Specifically, patients with depres-
sive symptoms were more likely to be female, were less
affluent, and were more likely to have diabetes, hypercho-
lesterolemia, and non-cardiac comorbidities. There were
no significant differences in baseline cardiovascular prog-
nosis (GRACE scores 109.5 vs. 113.0, p = 0.22), but
patients with depressive symptoms had poorer cardiovas-
cular functional status (DASI score 11.2 vs. 19.6, p <
0.001; lower score indicates worse peak oxygen
uptake)(Table 2).
Health service consumption
Total number of hospitalizations, total number of hospi-
talization days, length of hospital stays, and post-AMI
ambulatory service use were greater for patients with
depressive symptoms (Table 3).
After adjustment for age, sex, income, risk factors, medical
comorbidity, prognosis (GRACE score), drugs at dis-
charge, 30-day procedure use (percutaneous coronary
interventions and/or coronary artery bypass surgery), and
symptom burden (DASI), depressive symptoms remained
an independent predictor of most service consumption
measures, with a 24% (Adjusted RR:1.24, 95% CI:1.19–
1.30, P < 0.001) increase in all cause re-hospitalizations, a
9% (Adjusted RR:1.09; 95% CI:1.02–1.16, P = 0.007)
increase in cardiac-related hospitalizations and a 43%
(Adjusted RR:1.43; 95% CI:1.34–1.52, P < 0.001) increase
in non-cardiac hospitalizations visits following AMI dis-
charge (Figure 1). Depressive symptoms were associated
with increases in cardiology, internal medicine and family
practice visits after adjustment for baseline variables (Fig-
ure 1).
Cardiac-specific re-admissions were comprised mostly of
angina and CHF hospitalizations. Depressed patients
were substantially more likely to be admitted for angina
in the 18 months post-AMI than non-depressed patients
(HR 1.75; 95% C.I. 1.44 – 2.14), even when the DASI is
included in the model (HR 1.41; 95% C.I. 1.14–1.75).
However, after adjusting for emergency-room visits,
depression was no longer a significant predictor of hospi-
tal readmissions.
To evaluate whether depressive-associated increases in
health service consumption were consistent across cardiac
illness risk severity levels, subgroup analyses were per-
formed in which the sample was stratified according to
median GRACE prognostic index score and median DASI
scores. When stratifying patients around the median
GRACE or DASI scores, the increase in health service con-
sumption associated with depressive symptom burden
was disproportionately higher among patients with lower
GRACE scores (better cardiac prognostic risk) and higher
DASI scores (greater functional capacity) than among
their higher risk poorer functional capacity counterparts
(Table 4).Page 5 of 12
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Table 2: Baseline Characteristics
Depressed* Non-Depressed P Value
Characteristics (n = 494) (n = 1447)




> 74 20 21
Male Sex -- % 63 73 <0.001
Income, Canadian $ -- % <0.001
Low (<$30,000) 33 24
Intermediate ($30,000 – $59,999) 34 35
High (>$59,999) 33 42
Coronary Risk Factors -- %
Diabetes 29 22 0.001
Hypercholesterolemia 45 39 0.02
Hypertension 49 46 0.33
Smoking 43 39 0.08
Non-cardiac comorbidities -- %
None 6 9 <0.001
1 16 23
2 27 23
3 or more 51 46
Prognostic Indicators -- mean (SD)
GRACE 6-month prognostic index score 11.6 (30.3) 113.6 (28.5) 0.22
DASI Score§ 11.2 (8.4) 19.6 (11.8) <0.001
Processes of Care -- %
Percutaneous transluminal coronary angiography 8 8 0.97
Coronary angioplasty bypass grafting 12 10 0.28
ACE Inhibitor 63 62 0.64
Beta Blocker 68 70 0.44
Statin 55 55 0.89
Nitrate 37 31 0.01
*The depression measure is a depression scale containing 9 items from the Brief Carroll Depression Scale (BCDS)(cut-off score of 5).
Abbreviation: GRACE: Global Registry of Acute Coronary Events scale.
§Abbreviation: DASI: Duke Activity Status Index
Table 3: Health service consumption in depressed and non-depressed post-AMI patients.
Service Consumption Variable Depressed* Non-depressed P Value
Hospitalization -- mean (SD)
Total hospitalization days 8.5 (19.8) 5.5 (14.6) 0.002
Total cardiac hospitalization days 4.8 (10.2) 3.3 (7.6) 0.002
Total non-cardiac hospitalization days 3.7 (15.5) 2.3 (11.5) 0.06
Total number of hospitalizations 1.2 (1.7) 0.8 (1.2) <0.001
Total number of cardiac hospitalizations 0.7 (1.1) 0.5 (0.9) <0.001
Total number of non-cardiac hospitalizations 0.5 (1.1) 0.3 (0.7) 0.001
Ambulatory service consumption -- mean (SD)
Cardiologist visits 12.5 (11.5) 9.8 (10.2) <0.001
General internist visits 14.1 (26.0) 10.8 (20.9) 0.01
Family doctor visits 36.5 (25.3) 31.6 (24.6) <0.001
Emergency department visits 1.7 (2.3) 1.3 (1.9) <0.001
*The depression measure is a depression scale containing 9 items from the Brief Carroll Depression Scale (BCDS)(cut-off score of 5).
Hospitalization days are a count of total days in hospital over the 18-month follow-up period and can accumulate from multiple hospitalizations.
BMC Health Services Research 2008, 8:200 http://www.biomedcentral.com/1472-6963/8/200
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The adjusted relative rate of health service consumption attributable to depression*Figure 1
The adjusted relative rate of health service consumption attributable to depression.* All outcomes were adjusted 
for age, sex, income, cardiac risk factors, coronary artery bypass graft (CABG), percutaneous, transluminal coronary angiogra-
phy (PTCA), drugs at discharge, GRACE prognostic index score, and DASI score. Hospitalization days are a count of total days 
in hospital over the 18-month follow-up period and can accumulate from multiple hospitalizations. * The depression measure is 
a depression scale containing 9 items from the Brief Carroll Depression Scale (BCDS)(cut-off score of 5).  Total and cardiac 






BMC Health Services Research 2008, 8:200 http://www.biomedcentral.com/1472-6963/8/200Mortality and recurrent AMI
There was no significant difference in two-year mortality
(HR = 0.92; 95% CI 0.59–1.42), re-AMI (HR = 1.22; 95%
CI 0.89–1.66), or in the composite risk of death or recur-
rent AMI (Adjusted HR = 1.12; 95% CI 0.80–1.57)
between patients with and without depressive symptoms.
Sensitivity analyses
First, the relationship between depression and health serv-
ice consumption when using the 3 replacement items
yielded similar outcomes as those generated with the 9-
item BCDRS (see Additional file 1). Second variations in
the cutoff scores used to distinguish depressive from non-
depressive patients did not alter our results. For example,
scores of 4 or 6 using the 9-item BCDRS generated similar
results as a score of 5. Similarly, the use of the GUSTO
quality of life sub-study depression measure scale yielded
similar results as did our 9-item BCDRS. Finally, we used
multiple imputation to repeat the analyses to include 888
subjects with missing depression scores, which did not
substantively change the results from the complete data
analyses (Figure 2).
Table 4: The relative risks of health service utilization among those with (vs. without) depression after adjustment for baseline factors 
stratified by prognostic risk and functional capacity (among the entire AMI cohort, and among those in which death and recurrent AMI 
were excluded).*
Among the entire sample Among those without death or re-infarction
Low risk High risk Low risk High risk
Cardiac prognostic risk (GRACE Score) (n = 1079) (n = 862) (n = 995) (n = 709)
Hospitalization
Total hospitalization days# 1.45 (1.36–1.56) 1.13 (1.07–1.19) 1.43 (1.31–1.56) 1.15 (1.07–1.23)
Cardiac-related days# 1.41 (1.29–1.53) 0.97 (0.90–1.04) 1.32 (1.19–1.47) 0.97 (0.87–1.08)
Non-cardiac days 1.54 (1.37–1.74) 1.36 (1.27–1.47) 1.68 (1.44–1.95) 1.31 (1.19–1.43)
Ambulatory
Cardiologist visits 1.16 (1.11–1.21) 1.13 (1.08–1.19) 1.17 (1.11–1.23) 1.11 (1.06 (1.18)
Internist visits 1.12 (1.07–1.17) 1.04 (1.00–1.08) 1.04 (0.99–1.09) 1.14 (1.09–1.20)
GP visits 1.15 (1.12–1.18) 0.97 (0.95–1.00) 1.17 (1.14–1.21) 0.92 (0.90–0.95)
Total ER visits 1.21 (1.07–1.37) 0.98 (0.86–1.11) 1.24 (1.08–1.43) 1.01 (0.87–1.17)
High capacity Low capacity High capacity Low capacity
Functional capacity (DASI score§ (n = 922) (n = 1019) (n = 856) (n = 848)
Hospitalization§
Total hospitalization days# 1.96 (1.79–2.16) 1.09 (1.04–1.14) 1.56 (1.38–1.77) 1.24 (1.17–1.32)
Cardiac-related days# 1.13 (1.07–1.20) 0.91 (0.78–1.07) 1.17 (0.98–1.40) 1.19 (1.09–1.30)
Non-cardiac days 3.99 (3.51–4.53) 1.04 (0.97–1.12) 2.14 (1.79–2.54) 1.33 (1.22–1.45)
Ambulatory
Cardiologist visits 1.23 (1.15–1.32) 1.14 (1.10–1.18) 1.26 (1.17–1.35) 1.16 (1.11–1.21)
Internist visits 1.33 (1.24–1.43) 1.02 (0.98–1.05) 1.37 (1.28–1.48) 1.09 (1.05–1.13)
GP visits 1.28 (1.23–1.33) 0.98 (0.96–1.00) 1.25 (1.21–1.30) 1.00 (0.97–1.02)
Total ER visits 1.49 (1.24–1.79) 1.00 (0.91–1.11) 1.66 (1.37–2.01) 1.02 (0.91–1.16)
* All relative risks were adjusted for age, sex, income, pre-existing cardiovascular disease, pre-existing non-cardiovascular conditions, in-hospital 
processes of care, prognostic risk (GRACE and DASI). Abbreviation: AMI: Acute myocardial infarction. Interaction terms were included in models 
with the complete sample. Depression/GRACE score interactions were statistically significant for the following outcomes when death and 
recurrent AMI were included (General Practitioner (GP) Visits (P < 0.001) and when death and recurrent AMI were excluded: Total hospitalization 
days (P < 0.001); Total Cardiac-related hospitalization days (P < 0.001); Non-cardiac hospitalization days (P < 0.001); Cardiologist Visits (P = 0.02); 
Internist Visits (P = 0.05); GP visits (P < 0.001); and Total ER Counts (P = 0.002). Depression/DASI interactions were significant for the following 
outcomes when death and recurrent AMI were included: Total hospitalization days (P < 0.001); Non-cardiac hospitalization days (P < 0.001); GP 
Visits (P < 0.001); and Total Emergency Room (ER) Visits (P < 0.001). The depression/DASI interaction was also significant when death and 
recurrent AMI were excluded for the following outcomes: Total hospitalization days (P = 0.02); Non-cardiac hospitalization days (P = 0.004); GP 
Visits (P < 0.001) and Total ER Visits (P = 0.03). Depression status was based on the 9-item depression rating scale.
 Abbreviation: GRACE – Global Registry of Acute Coronary Events.
§ Abbreviation: DASI – Duke Activity Status Index
 Hospitalization days are a count of total days in hospital over the 18 month follow-up period and can accumulate from multiple hospitalizations.
# Total and cardiac hospitalization results excluded recurrent AMI hospitalizations.Page 8 of 12
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The relative rate of health service consumption attributable to depression* – multiple imputation resultsFigu e 2
The relative rate of health service consumption attributable to depression* – multiple imputation results. All 
outcomes were adjusted for age, sex, income, cardiac risk factors, coronary artery bypass graft (CABG), percutaneous, trans-
luminal coronary angiography (PTCA), drugs at discharge, GRACE prognostic index score, and DASI score. Hospitalization 
days are a count of total days in hospital over the 18-month follow-up period and can accumulate from multiple hospitaliza-
tions. * The depression measure is a depression scale containing 9 items from the Brief Carroll Depression Scale (BCDS)(cut-
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Depressive symptoms at one-month post-AMI were signif-
icantly associated with health service consumption in the
18 months post-AMI. The relationship between health
service consumption and depressive symptoms persisted
after adjusting for comorbidity and cardiac illness sever-
ity. Indeed, the relationship between cardiac health serv-
ice consumption and depressive symptoms was even
greater among those patients with lower as compared
with higher cardiac illness severity. In short, the increased
likelihood of health service consumption among AMI
patients were over and above that expected based on car-
diac illness severity alone.
In our sample, depressive symptoms were not associated
with increased mortality or recurrent AMI, which is con-
trary to previous evidence [26,27]. However, the associa-
tion between depression and cardiovascular outcomes
remains controversial [28,29] and the results of this study
are not sufficient to address the controversial prognostic
importance of depression definitively, especially given
inter-study differences in measurement and timing of
depression. It is conceivable that measuring depression at
one-month post-AMI conferred a survival bias for which
multiple imputation methods were unable to fully
address. A recent publication measuring depression
directly prior to one-month post-AMI found no associa-
tion between depression and mortality at either time
point after adjustment for covariates [30].
Our study demonstrated a significant interaction between
depression, prognostic severity and health service con-
sumption, such that higher health service use occurred
among patients of lower rather than higher cardiac sever-
ity – a distinct contrast to those patients without depres-
sive symptoms whose health service experiences better
mirrored their cardiac illness severity levels. Available evi-
dence has demonstrated a treatment-risk paradox
whereby service provision is paradoxically most intensive
among patients with lowest need [31,32]. Our study sug-
gests that the presence of depressive symptoms might par-
tially mediate the treatment-risk paradox.
Some have hypothesized that mental illness and/or psy-
chological phenomena such as somatization promote
health seeking behaviors [6,33]. Our results support such
hypotheses. Indeed, in our study, depression-associated
increases in the risk of recurrent hospitalization were no
longer significant after adjusting for ER visits, suggesting
that depression-readmission rates may be attributable to
patient health-seeking behaviors more so than physicians'
propensity to admit for more discretionary indica-
tions[34,35].
Our study has several important clinical and policy impli-
cations. Patients with depressive symptoms post-AMI
pose a serious challenge to physicians and health care sys-
tems. On one hand, such patients are sicker and may be
more likely to die following AMI, underscoring the need
for closer attentiveness and management[5]. On the other
hand, depressive patients consume significant amounts of
cardiac health services and may do so disproportionately
in relation to objective measures of prognostic or sympto-
matic burden. Integrated chronic cardiac care programs
are well-established and effective interventions for
patients post-AMI[36]. Community-based depression
interventions have also been shown to be effective at treat-
ing depression and improving quality of life[37]. Given
the benefits of both chronic vascular disease manage-
ment[36], depression case-management[37] and the high
prevalence of depression in patients post-AMI[38], our
study suggests that integrating depression screening and
case-management into existing cardiac secondary preven-
tion programs may be effective in improving the quality of
life of depressed post-MI patients, and in reducing the
apparent mismatch between need and service consump-
tion. The importance of systematic depression screening is
further underscored by the low detection rates of depres-
sion after AMI[39].
Our study has several noteworthy limitations. First, our
scale was designed to ascertain depressive symptoms
rather than depressive disorders and was missing 3 items
from the original, validated depression rating scale. Our
health service consumption findings were similar whether
the 9 items or 3 replacement items were used to define
depression. The comparability of results with these two
depression measures suggests that the two scales are meas-
uring the same construct. Second, depressive symptoms
were measured cross-sectionally and at one-month post-
AMI. As such, we could not determine the persistence of
depressive symptoms over the follow-up interval. The
delay in depression post-AMI also imposes a survival bias
on the sample. However, survival bias is less of an issue
with the main outcome of health service consumption,
since service consumption differences are only relevant in
those patients who survive long enough to use services.
Finally, information regarding depression was missing in
just over 30% of the potentially eligible respondent pop-
ulation. However, our sensitivity analyses utilizing
model-based multiple imputation to include those
patients with missing depression values provide evidence
that the missing values did not materially affect our find-
ings.
Conclusion
In conclusion, our study demonstrated the increased con-
sumption of health services among post-AMI patients
with depressive symptoms is independent of comorbidityPage 10 of 12
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BMC Health Services Research 2008, 8:200 http://www.biomedcentral.com/1472-6963/8/200and cardiac illness severity. Moreover, the interaction
between depression, health service utilization, and prog-
nosis such that increased cardiovascular health service
consumption patterns among AMI patients with depres-
sive symptoms was most pronounced among those of
lower rather than higher cardiac illness severity suggests
that cardiac health seeking behaviors among depressive
patients may be mediated by psychosocial factors in addi-
tion to objective measures of need. Future research must
evaluate whether systematic depression detection and
integrated chronic disease management systems improve
health service efficiency and allow for better alignment
between illness severity and health service consumption
among such patient populations.
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